dihydrochandonium iodide has been researched along with tubocurarine in 1 studies
| Studies (dihydrochandonium iodide) | Trials (dihydrochandonium iodide) | Recent Studies (post-2010) (dihydrochandonium iodide) | Studies (tubocurarine) | Trials (tubocurarine) | Recent Studies (post-2010) (tubocurarine) |
|---|---|---|---|---|---|
| 7 | 1 | 0 | 4,661 | 149 | 52 |
| Protein | Taxonomy | dihydrochandonium iodide (IC50) | tubocurarine (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 9.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Earnshaw, G; Hackett, GH; Jantzen, JP | 1 |
1 other study(ies) available for dihydrochandonium iodide and tubocurarine
| Article | Year |
|---|---|
Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs.
Topics: Androstanes; Animals; Atracurium; Cardiovascular System; Dogs; Hemodynamics; Male; Neuromuscular Blocking Agents; Pancuronium; Tubocurarine; Vecuronium Bromide | 1989 |